<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bone marrow is the primary site for many <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To date, however, no suitable bone marrow imaging method has been found </plain></SENT>
<SENT sid="2" pm="."><plain>The present study investigates the usefulness of bone marrow immunoscintigraphy using 99mTc-labeled antigranulocyte antibody (anti-NCA-95) in 31 patients with <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: One milligram of antibody labeled with 259-370 MBq 99mTc was injected intravenously, and bone marrow images were taken 4 hr later </plain></SENT>
<SENT sid="4" pm="."><plain>We also calculated the uptake ratios of lumbar bone marrow-to-background (L/B) and ilium-to-background (I/B) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Of 15 patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, 7 showed diffusely decreased antibody uptake (L/B = 2.3 +/- 0.8, I/B = 3.0 +/- 0.8) compared to control patients (n = 21, L/B = 8.2 +/- 2.5, I/B = 10.3 +/- 3.1) Six patients had both decreased and increased uptake areas and two had <z:mpath ids='MPATH_458'>normal</z:mpath> to slightly increased uptake </plain></SENT>
<SENT sid="6" pm="."><plain>Of those patients receiving various types of therapy for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0000001'>all</z:hpo> but one showed increased or irregular uptake </plain></SENT>
<SENT sid="7" pm="."><plain>The degree of antibody uptake in the bone marrow correlated with peripheral blood analyses (<z:chebi fb="0" ids="35143">hemoglobin</z:chebi>, white blood cells, platelets) </plain></SENT>
<SENT sid="8" pm="."><plain>Of six patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, four had irregular uptake and two diffusely decreased uptake </plain></SENT>
<SENT sid="9" pm="."><plain>Four patients with myelogenous <z:hpo ids='HP_0001909'>leukemia</z:hpo> showed <z:mpath ids='MPATH_458'>normal</z:mpath> uptake, whereas two with lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> had decreased uptake </plain></SENT>
<SENT sid="10" pm="."><plain>Patients with <z:hpo ids='HP_0001891'>iron deficiency anemia</z:hpo>, pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> or <z:e sem="disease" ids="C0085578,C0472766" disease_type="Disease or Syndrome" abbrv="">thalassemia minor</z:e> exhibited <z:mpath ids='MPATH_458'>normal</z:mpath> uptake with bone marrow expansion </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Immunoscintigraphy with antigranulocyte antibody is a useful method for evaluating the bone marrow status of patients with various <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> </plain></SENT>
</text></document>